Semisolid Dosage

Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of "ointments" as dosage forms was initiated in the 1950s. It was only from then on that the intensive phy...

Full description

Saved in:
Bibliographic Details
Other Authors: Daniels, Rolf (Editor), Lunter, Dominique (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_68985
005 20210501
003 oapen
006 m o d
007 cr|mn|---annan
008 20210501s2020 xx |||||o ||| 0|eng d
020 |a books978-3-03936-949-2 
020 |a 9783039369485 
020 |a 9783039369492 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03936-949-2  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Daniels, Rolf  |4 edt 
700 1 |a Lunter, Dominique  |4 edt 
700 1 |a Daniels, Rolf  |4 oth 
700 1 |a Lunter, Dominique  |4 oth 
245 1 0 |a Semisolid Dosage 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (182 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Even in ancient times, semi-solid preparations for cutaneous application, popularly known as ointments, played an important role in human society. An advanced scientific investigation of "ointments" as dosage forms was initiated in the 1950s. It was only from then on that the intensive physico-chemical characterization of ointments as well as the inclusion of dermatological aspects led to a comprehensive understanding of the various interactions between the vehicle, the active ingredient and the skin. From then on, many researchers were involved in optimizing semi-solid formulations with respect to continuously changing therapeutic and patient needs. Aspects that have been dealt with were the optimization of dermato-biopharmaceutical properties and many different issues related to patient compliance, such as skin tolerance, applicability, and cosmetic appeal. Moreover, processing technology has been improved and analytical techniques were developed and refined in order to enable the improved characterization of the formulation itself as well as its interaction with the skin. This Special Issue serves to highlight and capture the contemporary progress and current research on semi-solid formulations as dermal drug delivery systems. We invite articles on all aspects of semi-solid formulations, highlighting the research currently undertaken to improve and better understand these complex drug delivery systems with respect to their formulation, processing and characterization issues. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a dermal drug delivery 
653 |a diffusion cell 
653 |a Franz diffusion 
653 |a Skin-PAMPA 
653 |a Strat-M® membrane 
653 |a nanocarrier 
653 |a nonivamide 
653 |a methyl cellulose 
653 |a skin penetration 
653 |a substantivity 
653 |a thermogel 
653 |a tacrolimus formulation 
653 |a nanogels 
653 |a drug delivery 
653 |a human excised skin 
653 |a Jurkat cells 
653 |a in situ hydrogel-forming powder 
653 |a nitric oxide-releasing formulation 
653 |a S-nitrosoglutathione (GSNO) 
653 |a antibacterial 
653 |a wound dressing 
653 |a wound healing 
653 |a dermal delivery 
653 |a porcine skin 
653 |a in vitro permeation 
653 |a methadone 
653 |a pain 
653 |a in vitro 
653 |a permeation 
653 |a niacinamide 
653 |a solvent 
653 |a PAMPA 
653 |a skin 
653 |a curcumin 
653 |a deformable liposomes 
653 |a liposome surface charge 
653 |a hydrogel 
653 |a chitosan 
653 |a wound therapy 
653 |a IVRT 
653 |a metronidazole 
653 |a topical cream 
653 |a semisolid dosage forms 
653 |a sameness 
653 |a FDA's SUPAC-SS guidance 
653 |a acceptance criteria 
653 |a positive and negative controls 
653 |a discriminatory ability 
653 |a Amphotericin B 
653 |a Sepigel 305® 
653 |a Leishmania infantum 
653 |a cutaneous leishmaniasis 
653 |a topical treatment 
653 |a birch bark extract 
653 |a oleogels 
653 |a hydrogen bonding 
653 |a triterpene 
653 |a rheology 
653 |a gel strength 
653 |a eosinophilic esophagitis 
653 |a budesonide 
653 |a xanthan gum 
653 |a guar gum 
653 |a mucoadhesion 
653 |a esophagus permeability 
653 |a rheological characterization 
653 |a pediatric medicine 
653 |a compounded preparation 
653 |a non-ionic emulsifiers 
653 |a intercellular lipids 
653 |a confocal Raman spectroscopy (CRS) 
653 |a polyethylene glycol alkyl ethers 
653 |a polyethylene glycol sorbitan fatty acid esters 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/2753  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/68985  |7 0  |z DOAB: description of the publication